270 related articles for article (PubMed ID: 18487000)
1. Severe symptomatic hyponatremia during sibutramine therapy: a case report.
Esposito P; Rampino T; Gregorini M; Soccio G; Piotti G; Bedino G; Balenzano CT; Roscini E; Cosmai L; Portalupi V; Libetta C; Dal Canton A
Am J Kidney Dis; 2008 Jul; 52(1):137-9. PubMed ID: 18487000
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of a morbidly obese and growth-retarded adolescent with Williams-Beuren Syndrome by combining the medication of growth hormone and sibutramine.
Bahadori B; Uitz E; Tonninger-Bahadori K; Moghadasian MH
Singapore Med J; 2008 Jan; 49(1):e15-6. PubMed ID: 18204753
[TBL] [Abstract][Full Text] [Related]
3. Tolerability of sibutramine during a 6-week treatment period in high-risk patients with cardiovascular disease and/or diabetes: a preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial.
Maggioni AP; Caterson I; Coutinho W; Finer N; Gaal LV; Sharma AM; Torp-Pedersen C; Bacher P; Shepherd G; Sun R; James P;
J Cardiovasc Pharmacol; 2008 Nov; 52(5):393-402. PubMed ID: 19033818
[TBL] [Abstract][Full Text] [Related]
4. Catatonia and psychosis associated with sibutramine: a case report and pathophysiologic correlation.
Lee J; Teoh T; Lee TS
J Psychosom Res; 2008 Jan; 64(1):107-9. PubMed ID: 18158006
[TBL] [Abstract][Full Text] [Related]
5. A case of non-SIADH-induced hyponatremia in depression after treatment with reboxetine.
Koelkebeck K; Domschke K; Zwanzger P; Hetzel G; Lang D; Arolt V
World J Biol Psychiatry; 2009; 10(4 Pt 2):609-11. PubMed ID: 17965988
[TBL] [Abstract][Full Text] [Related]
6. Sibutramine as an adjuvant therapy in adolescents suffering from morbid obesity.
Reisler G; Tauber T; Afriat R; Bortnik O; Goldman M
Isr Med Assoc J; 2006 Jan; 8(1):30-2. PubMed ID: 16450748
[TBL] [Abstract][Full Text] [Related]
7. Influence of weight reduction by sibutramine on female sexual function.
Kim KK; Kang HC; Kim SS; Youn BB
Int J Obes (Lond); 2006 May; 30(5):758-63. PubMed ID: 16404407
[TBL] [Abstract][Full Text] [Related]
8. A possible mechanism for severe symptomatic hyponatremia during sibutramine therapy.
Magaldi AJ; Seguro AC
Am J Kidney Dis; 2008 Dec; 52(6):1197-8; author reply 1198. PubMed ID: 19026358
[No Abstract] [Full Text] [Related]
9. Sibutramine-associated adverse effects: a practical guide for its safe use.
Florentin M; Liberopoulos EN; Elisaf MS
Obes Rev; 2008 Jul; 9(4):378-87. PubMed ID: 18034790
[TBL] [Abstract][Full Text] [Related]
10. Sibutramine-associated QT interval prolongation and cardiac arrest.
Ernest D; Gershenzon A; Corallo CE; Nagappan R
Ann Pharmacother; 2008 Oct; 42(10):1514-7. PubMed ID: 18728104
[TBL] [Abstract][Full Text] [Related]
11. The effect of sibutramine therapy on occurrence of depression symptoms among obese patients.
Slovacek L; Pavlik V; Slovackova B
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):e43-4. PubMed ID: 18676135
[No Abstract] [Full Text] [Related]
12. [Questions surrounding sibutramine for obesity].
Nau JY
Rev Med Suisse; 2010 Jan; 6(231):76. PubMed ID: 20196440
[No Abstract] [Full Text] [Related]
13. Cocaine-associated acute severe hyponatremia.
Karim MR; Jawairia M; Rahman S; Balsam L; Rubinstein S
Clin Nephrol; 2011 Feb; 75 Suppl 1():11-5. PubMed ID: 21269586
[TBL] [Abstract][Full Text] [Related]
14. Sibutramine-associated psychosis (case report).
Gazdag G; Szabó Z
Neuropsychopharmacol Hung; 2008 May; 10(2):107-10. PubMed ID: 18959143
[TBL] [Abstract][Full Text] [Related]
15. Syndrome of inappropriate antidiuretic hormone secretion induced by amiodarone therapy.
Aslam MK; Gnaim C; Kutnick J; Kowal RC; McGuire DK
Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):831-2. PubMed ID: 15189547
[TBL] [Abstract][Full Text] [Related]
16. Proteome changes in rat plasma in response to sibutramine.
Choi JW; Joo JI; Kim DH; Wang X; Oh TS; Choi DK; Yun JW
Proteomics; 2011 Apr; 11(7):1300-12. PubMed ID: 21337517
[TBL] [Abstract][Full Text] [Related]
17. Sibutramine: balancing weight loss benefit and possible cardiovascular risk.
de Simone G; D'Addeo G
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):337-41. PubMed ID: 18502626
[No Abstract] [Full Text] [Related]
18. A case of sibutramine-induced hyperprolactinemia.
Soares Leaes CG; Pereira-Lima JF; da Costa Oliveira M
Neuro Endocrinol Lett; 2011; 32(5):616-8. PubMed ID: 22167128
[TBL] [Abstract][Full Text] [Related]
19. Sibutramine-induced acute myocardial infarction in a young lady.
Yim KM; Ng HW; Chan CK; Yip G; Lau FL
Clin Toxicol (Phila); 2008 Nov; 46(9):877-9. PubMed ID: 18788006
[TBL] [Abstract][Full Text] [Related]
20. Does long-term use of sibutramine (Meridia) result in continued weight loss in short-term responders?
Stevenson JH; Trojian T; Jackson EA
J Fam Pract; 2001 Dec; 50(12):1084. PubMed ID: 11742615
[No Abstract] [Full Text] [Related]
[Next] [New Search]
